Vital ingredient for blood vessel formation found

Monday, 25 March, 2019

Vital ingredient for blood vessel formation found

Researchers from the University of Virginia (UVA) have discovered an ingredient vital for proper blood vessel formation. Published in the journal Nature Communications, their breakthrough offers a new direction for treating a host of serious conditions — from diabetes to stroke — and explains why other promising treatments have failed.

Until now, scientists seeking to grow blood vessels have focused almost exclusively on growing only the inner layer of blood vessels, which are made up of endothelial cells. The hope was that these endothelial cells would then recruit any other cell types needed to form a complete, functional blood vessel.

But the UVA researchers have determined that those vessels can develop properly only if they’re grown in conjunction with another cell type, known as perivascular cells, including smooth muscle cells and pericytes. The researchers liken these perivascular cells to the outer support layers of a rubber hose or on automobile tyres, without which they burst or leak.

“Most of the studies of angiogenesis [blood vessel formation] have focused on the inner lining of the pipes themselves,” researcher Daniel L Hess said. “That’s fairly well understood. But it’s really not well understood how you get a complete functional blood vessel that can withstand the mechanical force exerted by blood pressure.”

UVA’s new discovery, which helps answer this query, was made possible by the convergence of research in two different labs. Hess was working on a model of peripheral artery disease in the labs of lead researcher Gary K Owens and Brian Annex in the Robert M. Berne Cardiovascular Research Center, while another researcher, Molly R Kelly-Goss, was working with a model of blood vessel growth she developed in the lab of Shayn M Peirce, of UVA’s Department of Biomedical Engineering.

By bringing those two models together, the researchers were able to determine the vital role of the perivascular cells in blood vessel formation and to identify a gene, Oct4, that is required for this process. Previously, Oct4 had been thought to be active only in embryonic stem cells during early development and to be permanently inactivated in adult organisms.

This belief persisted until two years ago, when the Owens lab showed the gene was reactivated within smooth muscle cells during formation of atherosclerotic plaques inside blood vessels and required for formation of a protective fibrous cap on those lesions that prevents them from rupturing and setting off a heart attack or stroke — analogous to a patch on a tyre. Now the lab has shown that Oct4 has an important role in the formation of the vessels themselves.

Using Kelly-Goss’s model, the researchers were able to examine blood vessel formation in real time, and found that vessels that lacked perivascular cell coverage formed incompletely and leaked blood. According to Owens, “Multiple failed trials assumed the perivascular cells were just passive followers” — but without them, he said, “the whole process comes to a halt”.

Importantly, the researchers found that endothelial cells and perivascular cells communicate with one another via Oct4-dependent processes and, without it, functional non-leaky blood vessels or blood vessel networks cannot form. Ultimately, that means that scientists must take a more sophisticated approach to growing new vessels — a process important in normal growth and reproduction as well as wound repair.

Image caption: Researchers Gary K Owens and Molly R Kelly-Goss work to understand angiogenesis, the formation of blood vessels.

Please follow us and share on Twitter and Facebook. You can also subscribe for FREE to our weekly newsletters and bimonthly magazine.

Related News

New drug candidate for active rheumatoid arthritis

In a large-scale, international study, 12.5 to 20% of patients who were given the drug on a daily...

Universal flu vaccine passes development milestones

Vaccitech has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the...

New regulator of immune responses identified

Scientists have discovered a new internal regulator that helps control the body's response to...

  • All content Copyright © 2019 Westwick-Farrow Pty Ltd